As of September 1, 2021, we are pleased to be part of D.A. Davidson & Co. We will continue serving our clients as part of their full-service Investment Banking Group. Click here to learn more about our combined strengths.
×

Archive for: October 31, 2017

Oct 31, 2017

Is Bioelectronic Medicine the Next, Next Thing for Big Pharma?

Healthcare IT, Healthcare Newsletter 0 Comments

Dear Clients and Friends, Please click here for our October HIT Market Update. According to PhRMS, it takes 10 years and $2.6 billion to bring a drug to market and only two out of ten approved medications produce revenues that exceed their R&D costs. Many expect the picture to worsen in the coming years. Perhaps it is time to invest less in chemical engineering and pay more attention to bioelectronic medicines. The vision for bioelectronic medicines is one of miniature, implantable devices that can be attached to individual peripheral nerves. The nervous system is essentially the body’s electrical and communication systems that…

Read More

Back to Top